Udvidet returret til d. 31. januar 2025

Risk-sharing in the Pharmaceutical Industry - Gerrit Reepmeyer - Bog

- The Case of Out-licensing

Bag om Risk-sharing in the Pharmaceutical Industry

Monopoly profits have started to decline and the average costs per new drug have reached a re cord level of close to US$ 1 billion today. As a result, any failure of a new sub stance in the R&D process can lead to considerable losses, and the risks of introduc ing a new drug to the market have grown tremendously.

Vis mere
  • Sprog:
  • Engelsk
  • ISBN:
  • 9783790816679
  • Indbinding:
  • Paperback
  • Sideantal:
  • 297
  • Udgivet:
  • 5. december 2005
  • Udgave:
  • 2006
  • Størrelse:
  • 234x156x16 mm.
  • Vægt:
  • 970 g.
  • 8-11 hverdage.
  • 9. december 2024

Normalpris

  • BLACK WEEK

Medlemspris

Prøv i 30 dage for 45 kr.
Herefter fra 79 kr./md. Ingen binding.

Beskrivelse af Risk-sharing in the Pharmaceutical Industry

Monopoly profits have started to decline and the average costs per new drug have reached a re cord level of close to US$ 1 billion today. As a result, any failure of a new sub stance in the R&D process can lead to considerable losses, and the risks of introduc ing a new drug to the market have grown tremendously.

Brugerbedømmelser af Risk-sharing in the Pharmaceutical Industry



Find lignende bøger
Bogen Risk-sharing in the Pharmaceutical Industry findes i følgende kategorier:

Gør som tusindvis af andre bogelskere

Tilmeld dig nyhedsbrevet og få gode tilbud og inspiration til din næste læsning.